Press releases
- BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
- BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
- BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
- BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
- BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
- BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
- BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
- BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
- BIO-TECHNE DECLARES DIVIDEND
- BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
More ▼
Key statistics
On Tuesday, Bio-Techne Corp (TE1:DEU) closed at 59.00, 19.43% above the 52 week low of 49.40 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 58.50 |
---|---|
High | 59.50 |
Low | 58.00 |
Bid | 59.00 |
Offer | 59.50 |
Previous close | 59.00 |
Average volume | 25.40 |
---|---|
Shares outstanding | 157.19m |
Free float | 155.66m |
P/E (TTM) | 45.30 |
Market cap | 9.87bn USD |
EPS (TTM) | 1.39 USD |
Annual div (ADY) | 0.2967 EUR |
---|---|
Annual div yield (ADY) | 0.50% |
Div ex-date | Feb 09 2024 |
Div pay-date | Feb 26 2024 |
Data delayed at least 15 minutes, as of Apr 23 2024.
More ▼